circle

A PIPELINE POWERED BYPASSION

PUBLICATIONS AND PRESENTATIONS

The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared with Outpatients

Poster, American College of Cardiology 71st Annual Scientific Session (ACC.22)
Docherty KF, et al
Washington, D.C.
April 3, 2022

Healthcare Resource Use, Intensity, and Costs Among Patients with Heart Failure with Reduced Ejection Fraction Treated with Omecamtiv Mecarbil in GALACTIC-HF

Poster, American College of Cardiology 71st Annual Scientific Session (ACC.22)
Desai NR, et al
Washington, D.C.
April 3, 2022

REDWOOD-HCM Cohort 3: Evidence for Clinical Efficacy of Aficamten in Patients with Obstructive HCM and HF Symptoms Refractory to Maximal Medical Therapy, Including Disopyramide

Poster, American College of Cardiology 71st Annual Scientific Session (ACC.22)
Owens AT, et al
Washington, D.C.
April 2, 2022

Influence of Atrial Fibrillation on Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure: the GALACTIC-HF Trial

European Heart Journal
Solomon SD, Claggett BL, Miao ZM, et al
March 23, 2022

Adverse Drug Effects Across Patients With Heart Failure: A Systematic Review

The American Journal of Managed Care
Butzner M, Riello RJ, Sarocco P, et al
March 14, 2022